RxDoctor Payments DataLook up a doctor →

Javier Alonso-Llamazares, PhD

Dermatology · Coral Gables, FLNPI 1356315485

Payments from drug & device makers

$5,599,193in general payments, 2019–2025

Across 2,468 payments — averaging $2268.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Research & Development, LLC$1.4M
  • Takeda Pharmaceuticals U.S.A., Inc.$918K
  • Eli Lilly$504K
  • E.r. Squibb & Sons, L.L.C.$494K
  • Incyte Corporation$377K
  • Arcutis Biotherapeutics, Inc.$244K
  • plus $1.7M from 49 others
$17,669in research payments, 2019–2025

Across 6 payments — averaging $2944.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$14K
  • Bausch Health US, LLC$3K
  • LEO Pharma AS$76

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Janssen Research & Development, LLC262$1,362,866
Takeda Pharmaceuticals U.S.A., Inc.52$918,065
Eli Lilly27$503,779
E.r. Squibb & Sons, L.L.C.63$493,801
Incyte Corporation303$376,700
Arcutis Biotherapeutics, Inc.329$243,798
Bausch Health US, LLC30$227,607
Sanofi US Services Inc.10$156,996
Lilly USA, LLC247$143,858
UCB, Inc.285$140,848
Journey Medical Corporation11$130,866
Amgen66$129,678
AbbVie(2 entities)103$126,709
Novartis43$106,054
UCB SA4$86,944
Bristol Myers Squibb30$85,253
LEO Pharma AS31$70,629
Aclaris Therapeutics, Inc.14$61,616
Sun Pharmaceutical Industries Inc.53$52,227
Galderma Laboratories, L.p.67$51,797
Kowa Pharmaceuticals America, Inc.26$30,904
Ortho Dermatologics, A Division Of Bausch Health US, LLC92$25,123
UCB Biosciences Inc.2$20,375
LEO Pharma Inc.67$19,842
Eli Lilly Export S.A. Puerto Rico Branch9$8,211
Dermira, Inc.11$8,180
EPI Health, LLC9$5,742
Perrigo Company PLC1$3,500
Pfizer42$1,026
Lumenis, Inc2$1,014
Sanofi28$892
VYNE Pharmaceuticals Inc.23$726
Johnson & Johnson28$687
Regeneron Healthcare Solutions, Inc.21$651
Almirall LLC8$382
Janssen Scientific Affairs, LLC3$339
Promius Pharma LLC3$184
Organogenesis Inc.3$167
Genentech USA, Inc.8$145
Merz North America, Inc.1$140
Mayne Pharma Commercial LLC10$135
Encore Dermatology Inc.9$130
Paratek Pharmaceuticals, Inc.6$121
Biofrontera Inc.7$121
Boehringer Ingelheim4$102
Sebela Pharmaceuticals Inc.3$66
DUSA Pharmaceuticals, Inc.2$36
Merck2$31
Strata Skin Sciences, Inc.2$24
Nabriva Therapeutics, PLC1$23
Verrica Pharmaceuticals Inc.1$20
Bioventus LLC1$17
Krystal Biotech Inc1$17
Botanix SB Inc1$17
Medimetriks Pharmaceuticals, Inc.1$14

How this compares

$5,599,193 in reported general payments places this provider in the 95th percentile of 1,147 dermatology providers in Florida.

See all dermatology providers in Florida

Medicare billing

Part B allowed, 2024
$276,162
Medicare patients
283
Services billed
5,647

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in Coral Gables

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →